Literature DB >> 21748056

Control and management of hypertension at a university health centre in oman.

Abdulaziz Almahrezi1, Ibrahim Al-Zakwani, Ayman Al-Aamri, Samia Al-Khaldi, Nisrin Al-Zadjali, Mohammed Al-Hatali, Abdullah Al-Shukeili.   

Abstract

OBJECTIVES: To evaluate the prevalence of hypertension, its control and management at Sultan Qaboos University (SQU) Health Centre, Oman.
METHODS: This was a retrospective cross-sectional study, in which were enrolled all the subjects (≥18 years), with the diagnosis of essential hypertension, who attended the SQU Health Centre between 1998 and 2002. The systolic and diastolic blood pressure (BP) values of the last three visits were used for analysis. BP control was defined using the Joint National Committee (JNC-7) criteria, <140 mmHg and <90 mmHg for systolic and diastolic BPs, respectively. Analyses were performed using univariate statistics.
RESULTS: Among the 7,702 medical records reviewed, the prevalence of hypertension was 2.4% (n = 187). The overall mean age of the cohort was 55±11 years, 54% (n = 101) were females, and majority of the subjects were Omanis (n = 123; 66%). The proportion of subjects who had their BP controlled was 41% (n = 77) with Omanis significantly less likely to have their BP controlled compared to non-Omanis (53% versus 35%; p = 0.017). The majority of the subjects were on mono (n = 131; 70%) followed by dual (n = 50; 27%) anti-hypertensive therapies. The most frequent mono anti-hypertensive therapies were B-blockers (n = 64; 34%) and angiotensin-converting enzyme (ACE) inhibitors (n = 47; 25%). Among the dual combination therapies, the most common prescribed regimens were ACE inhibitor plus B-blocker (n = 14; 28%) and B-blocker plus diuretic (n = 12; 24%).
CONCLUSION: The prevalence of hypertension in this patient population was low compared to the national average. This study shows that control of hypertension is not optimal, but higher than those reported elsewhere.

Entities:  

Keywords:  Disease management; Hypertension; Oman; Prevention and control

Year:  2008        PMID: 21748056      PMCID: PMC3074826     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  27 in total

1.  Combination Drug Therapy in the Management of Hypertension: When, With What, and How?

Authors:  Marvin Moser; Thomas Pickering; James R. Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2000-03       Impact factor: 3.738

Review 2.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

3.  Management of hypertensive patients in primary health care setting, auditing the practice.

Authors:  Mohammed O Al-Rukban; Abdurrahman M Al-Sughair; Bader O Al-Bader; Bader A Al-Tolaihi
Journal:  Saudi Med J       Date:  2007-01       Impact factor: 1.484

4.  Racial differences in blood pressure control: potential explanatory factors.

Authors:  Hayden B Bosworth; Tara Dudley; Maren K Olsen; Corrine I Voils; Benjamin Powers; Mary K Goldstein; Eugene Z Oddone
Journal:  Am J Med       Date:  2006-01       Impact factor: 4.965

5.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

6.  Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects.

Authors:  E Casiglia; G Zanette; A Mazza; V Donadon; C Donada; A Pizziol; V Tikhonoff; P Palatini; A C Pessina
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

7.  Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study.

Authors:  B M Psaty; C D Furberg; L H Kuller; M Cushman; P J Savage; D Levine; D H O'Leary; R N Bryan; M Anderson; T Lumley
Journal:  Arch Intern Med       Date:  2001-05-14

8.  Treatment of hypertension in Bahrain.

Authors:  Khalid A Jassim Al Khaja; Reginald P Sequeira; Awatif H H Damanhori
Journal:  Ann Pharmacother       Date:  2003-10       Impact factor: 3.154

Review 9.  Worldwide prevalence of hypertension: a systematic review.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul K Whelton; Jiang He
Journal:  J Hypertens       Date:  2004-01       Impact factor: 4.844

10.  The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.

Authors:  Jonathan C Fox; Kellie Leight; Santosh C Sutradhar; Laura A Demopoulos; Gilbert W Gleim; Andrew J Lewin; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-08       Impact factor: 3.738

View more
  3 in total

1.  Hypertension in Oman: Where Do We Stand?

Authors:  Ibrahim Al-Zakwani; Khamis Al-Hashmi
Journal:  Oman Med J       Date:  2018-09

2.  Prevalence of uncontrolled hypertension in primary care settings in Al seeb wilayat, oman.

Authors:  Rashid Al-Saadi; Sulaiman Al-Shukaili; Suleiman Al-Mahrazi; Zakiya Al-Busaidi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-08-15

3.  Quality of hypertension care in the family practice center, Aseer Region, Saudi Arabia.

Authors:  Yahia M Al-Khaldi
Journal:  J Family Community Med       Date:  2011-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.